WCG ThreeWire is a global, full-service patient recruitment provider that partners with pharmaceutical, biotech companies, and clinical research organizations to improve the bandwidth, productivity, and performance of their clinical research sites. Informed by our individual site resource evaluations, WCG ThreeWire is able to implement a customized solution that is tailored to the unique needs of every site in a clinical trial. At WCG ThreeWire, we believe that our unique ability to identify and remediate the root causes poor enrollment allows our clients to experience unmatched control and predictability over their enrollment outcomes. In 2017, WCG ThreeWire became a wholly owned subsidiary company of the WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG ThreeWire and WCG’s high-quality solutions are the key that sponsors desire to allow their studies run smoothly from beginning to end. As clinical trials continue to increase in size and complexity, it can be challenging for study sponsors and sites to find efficient, cost-effective ways to connect with the right patients. WCG ThreeWire provides a dedicated, patient-focused approach to ensure we are doing everything we can for every trial and most importantly, every patient.